Postmenopausal Alopecia Due to Ovarian Hyperandrogenemia Treated With Bilateral Salpingo-Oophorectomy

January 2020 in “ Journal of South Asian Federation of Obstetrics and Gynaecology ”

Santanu Acharya, Srirupa Chakravorty, DAVID W. RAE

postmenopausal alopecia ovarian hyperandrogenemia male-pattern baldness elevated testosterone GnRH analog bilateral salpingo-oophorectomy androgen levels ovarian hyperandrogenism hair loss testosterone GnRH analogs ovary removal

Studysummary In this case study, laparoscopic bilateral salpingo-oophorectomy was associated with reduced androgen levels and partial reversal of male-pattern hair loss in a postmenopausal woman with ovarian hyperandrogenism.

Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer

A 65-year-old postmenopausal woman experienced male-pattern baldness due to ovarian hyperandrogenemia, confirmed by elevated testosterone levels of ovarian origin using a GnRH analog. Treatment with laparoscopic bilateral salpingo-oophorectomy successfully reduced her androgen levels and partially reversed her hair loss over a year. This case demonstrated the effectiveness of using GnRH analogs for diagnosis and surgical removal of the ovaries in managing alopecia caused by ovarian hyperandrogenism.

View this study on doi.org →

Discuss this study in the Community →

Research cited in this study

3 / 3 results

Epidemiology, Diagnosis, and Management of Hirsutism: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome Society

research Epidemiology, Diagnosis, and Management of Hirsutism: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome Society

378 citations , November 2011 in “Human reproduction update”

This review discusses the epidemiology, causes, diagnosis, and management of hirsutism in women, noting that effective treatment requires addressing the root cause as well as the hair growth.

research How Should Postmenopausal Androgen Excess Be Evaluated?

63 citations , March 2011 in “Clinical Endocrinology”

This review examines the evaluation and management of hirsutism and hyperandrogenism in postmenopausal women and reports no new clinical findings.

Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome Society

research Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome Society

815 citations , April 2010 in “The Journal of Clinical Endocrinology & Metabolism”

This review examines the relationship between polycystic ovary syndrome and cardiovascular disease risk, but reports no new clinical findings; the panel calls for guidelines to prevent CVD in this population.